Rhinoscleroma: a growing concern in the United States? Mayo Clinic experience. NLM AIDSLINE Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Rhinoscleroma: a growing concern in the United States? Mayo Clinic experience.

Mayo Clin Proc. 1993 Dec;68(12):1151-7. Unique Identifier : AIDSLINE MED/94066571
Andraca R; Edson RS; Kern EB; Department of Otorhinolaryngology, Mayo Clinic Rochester,; Minnesota 55905.


Abstract: Rhinoscleroma is a chronic, progressive, granulomatous infection of the upper airways caused by the bacterium Klebsiella rhinoscleromatis. Although most cases occur in developing countries, recent immigration patterns have led to an increasing number of patients with rhinoscleroma in the United States. Rhinoscleroma may mimic various inflammatory and neoplastic processes, including leprosy, paracoccidioidomycosis, sarcoidosis, basal cell carcinoma, and Wegener's granulomatosis. Current therapy consists of a combination of surgical debridement and prolonged antimicrobial therapy. Rhinoscleroma should be added to the list of opportunistic infections that can occur in patients with human immunodeficiency virus.
Keywords: Adult Antibiotics/THERAPEUTIC USE Case Report Combined Modality Therapy Debridement Diagnosis, Differential Female Human Male Retrospective Studies Rhinoscleroma/DIAGNOSIS/*EPIDEMIOLOGY/THERAPY United States/EPIDEMIOLOGY JOURNAL ARTICLEKWDadultantibiotics/therapeuticusecasereportcombinedmodalitytherapydebridementdiagnosis,differentialfemalehumanmaleretrospectivestudiesrhinoscleroma/diagnosis/KWDepidemiology/therapyunitedstates/epidemiologyjournalarticle
940330
M9430841

Copyright © 1994 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .